Inventor · disambiguated record
Andrew Parsons
Also filed as: PARSONS ANDREW · PARSONS ANDREW A · PARSONS ANDREW T · PARSONS ANDREW THOMAS
7 granted patents·10 pending applications·45 citations·filing 1996–2025
81Inventor score
Top patents by PatentIndex Score
17 records- 0195US11299491B2Synthesis of key intermediate of KRAS G12C inhibitor compoundAMGEN INC·Filed 2019·Granted Apr 12, 2022·20 cites·1 claims
- 0288US12441729B2Process for preparing 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dioneAMGEN INC·Filed 2024·Granted Oct 14, 2025·2 cites·22 claims
- 0387US2025368642A1Synthesis of key intermediate of kras g12c inhibitor compoundAMGEN INC·Filed 2025·Application pending·0 cites
- 0487US2025368643A1Synthesis of key intermediate of kras g12c inhibitor compoundAMGEN INC·Filed 2025·Application pending·0 cites
- 0586US12391691B2Synthesis of key intermediate of KRAS G12C inhibitor compoundAMGEN INC·Filed 2024·Granted Aug 19, 2025·0 cites·14 claims
- 0681US2025388579A1Synthesis of kras g12c inhibitor compoundAMGEN INC·Filed 2025·Application pending·0 cites
- 0779US2025179068A1Synthesis of kras g12c inhibitor compoundAMGEN INC·Filed 2024·Application pending·0 cites
- 0876US12391689B2Synthesis of key intermediate of KRAS G12C inhibitor compoundAMGEN INC·Filed 2022·Granted Aug 19, 2025·0 cites·13 claims
- 0970US12466825B2Synthesis of KRAS G12C inhibitor compoundAMGEN INC·Filed 2020·Granted Nov 11, 2025·0 cites·42 claims
- 1063US6107328AUse of 5HT1B receptor antagonist for the treatment of vascular diseaseSMITHKLINE BEECHAM PLC·Filed 1996·Granted Aug 22, 2000·23 cites·4 claims
- 1161US2025122197A1Process for racemizing and isolating atropisomers of 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dioneAMGEN INC·Filed 2024·Application pending·0 cites
- 1258US2024025896A1Process for preparing 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dioneAMGEN INC·Filed 2021·Application pending·0 cites
- 1356US2023391771A1Process for racemizing and isolating atropisomers of 7-chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1h,3h)-dioneAMGEN INC·Filed 2021·Application pending·0 cites
- 1455US2003069300A1Use of benzopyranols to treat neurological disordersSMITHKLINE BEECHAM PLC·Filed 2002·Application pending·0 cites
- 1553US6492415B2Use of benzopyranols to treat neurological disordersSMITHKLINE BEECHAM PLC·Filed 2001·Granted Dec 10, 2002·0 cites·9 claims
- 1637US2011319482A1Novel treatmentsBLOWER PETER·Filed 2009·Application pending·0 cites
- 1734US2005171084A1Methods of treatment with lxr modulatorsFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Parsons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →